SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1
Authors
Keywords
-
Journal
Cell and Bioscience
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-23
DOI
10.1186/s13578-022-00770-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors
- (2022) Gustavo R. Perez-Lemus et al. Science Advances
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19
- (2021) Claude Kwe Yinda et al. PLoS Pathogens
- Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
- (2021) Jing-wen Lin et al. Cell Host & Microbe
- Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh
- (2021) Md. Jahidul Hasan et al. BMC INFECTIOUS DISEASES
- SARS-CoV-2 non-structural protein 1 inhibits the interferon response by causing depletion of key host signaling factors.
- (2021) Anil Kumar et al. JOURNAL OF VIROLOGY
- Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
- (2021) Shuofeng Yuan et al. NATURE
- Structural basis for backtracking by the SARS-CoV-2 replication–transcription complex
- (2021) Brandon Malone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
- (2021) Manuel Hayn et al. Cell Reports
- SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
- (2021) Bingyu Yan et al. Science Immunology
- Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
- (2021) Jingkun Zeng et al. BIOCHEMICAL JOURNAL
- An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15
- (2021) Jason K. Perry et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase
- (2021) Rajat Nandi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity
- (2021) Myung-Ho Kim et al. JOURNAL OF INFECTIOUS DISEASES
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms
- (2021) Christine Vazquez et al. PLoS One
- Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
- (2021) Joseph A. Newman et al. Nature Communications
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
- (2020) Wei Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Activation and evasion of type I interferon responses by SARS-CoV-2
- (2020) Xiaobo Lei et al. Nature Communications
- SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
- (2020) Lisa Miorin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
- (2020) Shuofeng Yuan et al. Nature Microbiology
- SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
- (2020) Jingfang Mu et al. Cell Discovery
- Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis
- (2020) Liming Yan et al. CELL
- Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis
- (2019) Zhihui Jia et al. NUCLEIC ACIDS RESEARCH
- Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
- (2019) Nicholas P. D. Liau et al. Cancers
- Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein
- (2017) Vidyanath Chaudhary et al. JOURNAL OF VIROLOGY
- Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro
- (2017) Yaoxing Wu et al. Cell Discovery
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses
- (2014) Adeyemi O. Adedeji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- I B kinase (IKK ) regulates the balance between type I and type II interferon responses
- (2011) S.-L. Ng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ Complex
- (2009) Kam-Leung Siu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential Inhibitory Activities and Stabilisation of DNA Aptamers against the SARS Coronavirus Helicase
- (2008) Ka To Shum et al. CHEMBIOCHEM
- Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase
- (2007) Kyoung Jin Jang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now